tradingkey.logo

Sharps Technology Inc

STSS
1.650USD
+0.225+15.79%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
45.58MMarktkapitalisierung
VerlustKGV TTM

Sharps Technology Inc

1.650
+0.225+15.79%

mehr Informationen über Sharps Technology Inc Unternehmen

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Sharps Technology Inc Informationen

BörsenkürzelSTSS
Name des UnternehmensSharps Technology Inc
IPO-datumApr 14, 2022
CEOMr. Robert M. Hayes
Anzahl der mitarbeiter5
WertpapierartOrdinary Share
GeschäftsjahresendeApr 14
Addresse105 Maxess Road
StadtMELVILLE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl11747
Telefon15162464000
Websitehttps://sharpstechnology.com/
BörsenkürzelSTSS
IPO-datumApr 14, 2022
CEOMr. Robert M. Hayes

Führungskräfte von Sharps Technology Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
14.04K
+14040.00%
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Yuwen (Alice) Zhang
Ms. Yuwen (Alice) Zhang
Chief Investment Officer, Director
Chief Investment Officer, Director
14.04K
+14040.00%
Mr. Andrew R. Crescenzo, CPA
Mr. Andrew R. Crescenzo, CPA
Chief Financial Officer
Chief Financial Officer
2.00
--
Mr. Paul K. Danner
Mr. Paul K. Danner
Executive Chairman of the Board, Principal Executive Officer
Executive Chairman of the Board, Principal Executive Officer
--
--
Mr. Timothy J. Ruemler
Mr. Timothy J. Ruemler
Independent Director
Independent Director
--
--
Mr. Jason L. Monroe
Mr. Jason L. Monroe
Independent Director
Independent Director
--
--
Mr. Adam Holdsworth
Mr. Adam Holdsworth
Investor Relations
Investor Relations
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Feb 1
Aktualisiert: Sun, Feb 1
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Saba Capital Management, L.P.
10.52%
Schonfeld Strategic Advisors LLC
5.31%
Bastion Trading Ltd
4.93%
Pantera Capital Partners LP
3.97%
The Vanguard Group, Inc.
1.80%
Andere
73.48%
Aktionäre
Aktionäre
Anteil
Saba Capital Management, L.P.
10.52%
Schonfeld Strategic Advisors LLC
5.31%
Bastion Trading Ltd
4.93%
Pantera Capital Partners LP
3.97%
The Vanguard Group, Inc.
1.80%
Andere
73.48%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
10.56%
Investment Advisor
6.50%
Hedge Fund
5.31%
Corporation
4.93%
Pension Fund
0.28%
Individual Investor
0.12%
Research Firm
0.08%
Venture Capital
0.04%
Andere
72.18%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
42
5.29M
18.26%
+3.62M
2025Q3
32
24.05K
0.09%
-49.29K
2025Q2
33
49.45K
5.94%
+26.45K
2025Q1
39
63.33K
6.22%
+60.72K
2024Q4
33
355.71K
5.82%
+134.96K
2024Q3
33
124.60K
7.17%
-86.28K
2024Q2
32
148.09K
20.99%
+9.96K
2024Q1
27
169.97K
24.07%
+27.63K
2023Q4
28
254.51K
44.37%
+113.61K
2023Q3
28
231.44K
42.60%
+113.95K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Schonfeld Strategic Advisors LLC
1.54M
5.45%
+1.54M
--
Sep 30, 2025
Pantera Capital Partners LP
1.15M
4.07%
+1.15M
--
Sep 30, 2025
The Vanguard Group, Inc.
17.85K
0.06%
+5.59K
+45.56%
Sep 30, 2025
Voya Investments, LLC
183.34K
0.65%
+183.34K
--
Oct 31, 2025
OMERS Administration Corporation
81.33K
0.29%
+81.33K
--
Sep 30, 2025
Ruemler (Timothy James)
20.22K
0.07%
+57.00
+0.28%
Sep 09, 2025
Zhang (Yuwen)
14.04K
0.05%
+14.04K
--
Sep 09, 2025
Mehr Anzeigen

Verbundene ETFs

Name
Anteil
Keine Daten

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Apr 24, 2025
Merger
300→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Datum
Ex-Dividendentag
Art
Verhältnis
Apr 24, 2025
Merger
300→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
Sep 12, 2024
Merger
22→1
KeyAI